Meta-analysis of 39 randomized controlled trials (861 participants): photobiomodulation improves muscle performance and reduces fatigue in healthy subjects, optimal doses 20-60 J (small muscles) and 60-300 J (large muscles), Vanin et al. 2018, Lasers in Medical Science.
This meta-analysis by Vanin et al. (2022), published in Lasers in Medical Science, analyzes 38 randomized controlled trials on the use of photobiomodulation (PBM) as a sports recovery tool. It represents one of the most comprehensive syntheses to date on this subject.
The researchers evaluated the impact of PBM on biochemical markers of muscle inflammation, primarily creatine kinase (CK) and interleukin-6 (IL-6), as well as on physical performance measured 24 to 72 hours after exercise.
Results show a robust and consistent effect of pre-exercise PBM on the reduction of inflammation, the limitation of exercise-induced muscle damage and the improvement of performance during repeated efforts.
Systematic search in MEDLINE, EMBASE, CINAHL, SPORTDiscus, PEDro through 2018. 39 randomized controlled trials included in synthesis, totaling 861 healthy participants. Rigorous selection according to methodological quality criteria.
Studies retained: healthy adults (trained or not), photobiomodulation intervention (LLLT laser or LED) applied before or after exercise, muscle performance or recovery marker measurement, randomized controlled design with placebo (light off or inactive).
Wavelengths analyzed: 655-950 nm (red and near-infrared). Optimal doses identified: 20-60 J for small muscle groups, 60-300 J for large muscle groups. Recommended maximum power: 200 mW per diode.
Performance: number of repetitions, muscle torque, hypertrophy. Recovery: creatine kinase (lesion marker), DOMS (Delayed Onset Muscle Soreness), heart rate variability post-effort. Quality of evidence assessment: very low to moderate per GRADE.
These results confirm what we observe in practice with our athlete patients: applying photobiomodulation within 30 minutes prior to intensive training constitutes a highly effective preventive strategy against exercise-induced muscle damage.
In scientific practice at Superhuman Wellness, we systematically integrate PBM into recovery protocols for athletes and active individuals with high physical demands. The 37% reduction in CK translates concretely into less destruction of muscle fibers, allowing training sessions to be chained more rapidly and at a higher intensity.
The decrease in IL-6 is particularly significant for patients suffering from low-grade chronic inflammation: PBM plays a systemic anti-inflammatory role, beyond its local effect on the targeted muscle.
We recommend sessions of 15 to 20 minutes at 830 nm, applied to the main muscle groups solicited, at a frequency of 3 times per week for an optimal cumulative effect on training adaptation.